Cargando…
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
BACKGROUND: Rituximab is a promising steroid sparing agent used in the treatment of moderate to severe pemphigus vulgaris. Its exact place in the algorithm of pemphigus treatment, vis-à-vis other, conventional adjuvant therapy (CAT) is not known. OBJECTIVE: To describe and compare disease course out...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155499/ https://www.ncbi.nlm.nih.gov/pubmed/30252855 http://dx.doi.org/10.1371/journal.pone.0198074 |